Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Peripheral Blood Cell Interactions of Cancer-Derived Exosomes Affect Immune Function.

Ferguson Bennit HR, Gonda A, McMullen JRW, Kabagwira J, Wall NR.

Cancer Microenviron. 2018 Mar 30. doi: 10.1007/s12307-018-0209-1. [Epub ahead of print]

PMID:
29603062
2.

Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients.

Khan S, Simpson J, Lynch JC, Turay D, Mirshahidi S, Gonda A, Sanchez TW, Casiano CA, Wall NR.

PLoS One. 2017 Oct 5;12(10):e0183122. doi: 10.1371/journal.pone.0183122. eCollection 2017.

3.

Differential protein expression in exosomal samples taken from trauma patients.

Moyron RB, Wall NR.

Proteomics Clin Appl. 2017 Sep;11(9-10). doi: 10.1002/prca.201700095. No abstract available.

PMID:
28734082
4.

Therapeutic Application of Natural Medicine Monomers in Cancer Treatment.

Zhong C, Wall NR, Zu Y, Sui G.

Curr Med Chem. 2017 Nov 17;24(34):3681-3697. doi: 10.2174/0929867324666170714101503. Review.

PMID:
28714385
5.

Making Meaningful Clinical Use of Biomarkers.

Selleck MJ, Senthil M, Wall NR.

Biomark Insights. 2017 Jun 19;12:1177271917715236. doi: 10.1177/1177271917715236. eCollection 2017. Review.

6.

Differential protein expression in exosomal samples taken from trauma patients.

Moyron RB, Gonda A, Selleck MJ, Luo-Owen X, Catalano RD, O'Callahan T, Garberoglio C, Turay D, Wall NR.

Proteomics Clin Appl. 2017 Sep;11(9-10). doi: 10.1002/prca.201700061. Epub 2017 Jul 10.

PMID:
28544811
7.

Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy.

McMullen JRW, Selleck M, Wall NR, Senthil M.

Oncotarget. 2017 Jun 27;8(26):43481-43490. doi: 10.18632/oncotarget.16480. Review.

8.

Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis.

Galloway NR, Ball KF, Stiff T, Wall NR.

Crit Rev Oncog. 2017;22(1-2):23-36. doi: 10.1615/CritRevOncog.2017020836.

PMID:
29604934
9.

Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.

Sanchez TW, Zhang G, Li J, Dai L, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang JY, Casiano CA.

Mol Cell Proteomics. 2016 Dec;15(12):3564-3580. Epub 2016 Oct 14.

10.

Brain-Wide Maps of Synaptic Input to Cortical Interneurons.

Wall NR, De La Parra M, Sorokin JM, Taniguchi H, Huang ZJ, Callaway EM.

J Neurosci. 2016 Apr 6;36(14):4000-9. doi: 10.1523/JNEUROSCI.3967-15.2016.

11.

Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients.

Turay D, Khan S, Diaz Osterman CJ, Curtis MP, Khaira B, Neidigh JW, Mirshahidi S, Casiano CA, Wall NR.

Cancer Invest. 2016;34(1):1-11. doi: 10.3109/07357907.2015.1081921. Epub 2015 Nov 4.

12.

Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis.

Díaz Osterman CJ, Gonda A, Stiff T, Sigaran U, Valenzuela MM, Ferguson Bennit HR, Moyron RB, Khan S, Wall NR.

Pancreas. 2016 Jan;45(1):101-9. doi: 10.1097/MPA.0000000000000411.

13.

Localization and upregulation of survivin in cancer health disparities: a clinical perspective.

Khan S, Ferguson Bennit H, Asuncion Valenzuela MM, Turay D, Diaz Osterman CJ, Moyron RB, Esebanmen GE, Ashok A, Wall NR.

Biologics. 2015 Jul 9;9:57-67. doi: 10.2147/BTT.S83864. eCollection 2015. Review.

14.

Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function.

Osterman CJ, Lynch JC, Leaf P, Gonda A, Ferguson Bennit HR, Griffiths D, Wall NR.

PLoS One. 2015 Jul 15;10(7):e0132845. doi: 10.1371/journal.pone.0132845. eCollection 2015.

15.

Antimetabolite Treatment for Pancreatic Cancer.

Valenzuela MM, Neidigh JW, Wall NR.

Chemotherapy (Los Angel). 2014 Dec;3(3). pii: 137.

16.

AML sensitivity to YM155 is modulated through AKT and Mcl-1.

de Necochea-Campion R, Diaz Osterman CJ, Hsu HW, Fan J, Mirshahidi S, Wall NR, Chen CS.

Cancer Lett. 2015 Sep 28;366(1):44-51. doi: 10.1016/j.canlet.2015.05.034. Epub 2015 Jun 25.

17.

Exosomes Secreted from Human Cancer Cell Lines Contain Inhibitors of Apoptosis (IAP).

Valenzuela MM, Ferguson Bennit HR, Gonda A, Diaz Osterman CJ, Hibma A, Khan S, Wall NR.

Cancer Microenviron. 2015 Aug;8(2):65-73. doi: 10.1007/s12307-015-0167-9. Epub 2015 May 16.

18.

Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase.

Asuncion Valenzuela MM, Castro I, Gonda A, Diaz Osterman CJ, Jutzy JM, Aspe JR, Khan S, Neidigh JW, Wall NR.

Onco Targets Ther. 2015 Feb 26;8:495-507. doi: 10.2147/OTT.S79647. eCollection 2015.

19.

Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons.

Lammel S, Steinberg EE, Földy C, Wall NR, Beier K, Luo L, Malenka RC.

Neuron. 2015 Jan 21;85(2):429-38. doi: 10.1016/j.neuron.2014.12.036.

20.

The emerging role of exosomes in survivin secretion.

Khan S, Bennit HF, Wall NR.

Histol Histopathol. 2015 Jan;30(1):43-50. doi: 10.14670/HH-30.43. Epub 2014 Jul 14. Review.

21.

Characterization of long descending premotor propriospinal neurons in the spinal cord.

Ni Y, Nawabi H, Liu X, Yang L, Miyamichi K, Tedeschi A, Xu B, Wall NR, Callaway EM, He Z.

J Neurosci. 2014 Jul 9;34(28):9404-17. doi: 10.1523/JNEUROSCI.1771-14.2014.

22.

Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant.

Aspe JR, Diaz Osterman CJ, Jutzy JM, Deshields S, Whang S, Wall NR.

J Extracell Vesicles. 2014 Feb 17;3. doi: 10.3402/jev.v3.23244. eCollection 2014.

23.

Early diagnostic value of survivin and its alternative splice variants in breast cancer.

Khan S, Bennit HF, Turay D, Perez M, Mirshahidi S, Yuan Y, Wall NR.

BMC Cancer. 2014 Mar 12;14:176. doi: 10.1186/1471-2407-14-176.

24.

Yin Yang 1 regulates the transcriptional repression of Survivin.

Galloway NR, Diaz Osterman CJ, Reiber K, Jutzy JM, Li F, Sui G, Soto U, Wall NR.

Biochem Biophys Res Commun. 2014 Feb 28;445(1):208-13. doi: 10.1016/j.bbrc.2014.01.169. Epub 2014 Feb 4.

25.

Combination antiangiogenic therapy and radiation in head and neck cancers.

Hsu HW, Wall NR, Hsueh CT, Kim S, Ferris RL, Chen CS, Mirshahidi S.

Oral Oncol. 2014 Jan;50(1):19-26. doi: 10.1016/j.oraloncology.2013.10.003. Epub 2013 Oct 23. Review.

PMID:
24269532
26.

Differential innervation of direct- and indirect-pathway striatal projection neurons.

Wall NR, De La Parra M, Callaway EM, Kreitzer AC.

Neuron. 2013 Jul 24;79(2):347-60. doi: 10.1016/j.neuron.2013.05.014. Epub 2013 Jun 27.

27.

Clinico-pathologic relevance of Survivin splice variant expression in cancer.

Necochea-Campion Rd, Chen CS, Mirshahidi S, Howard FD, Wall NR.

Cancer Lett. 2013 Oct 10;339(2):167-74. doi: 10.1016/j.canlet.2013.06.007. Epub 2013 Jun 18. Review.

28.

Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.

Khan S, Jutzy JM, Valenzuela MM, Turay D, Aspe JR, Ashok A, Mirshahidi S, Mercola D, Lilly MB, Wall NR.

PLoS One. 2012;7(10):e46737. doi: 10.1371/journal.pone.0046737. Epub 2012 Oct 16.

29.

Colorectal cancer screening using protected microRNAs.

Wall NR.

J Gastrointest Oncol. 2011 Dec;2(4):206-7. doi: 10.3978/j.issn.2078-6891.2011.040. No abstract available.

30.

Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro.

Jutzy JM, Khan S, Asuncion-Valenzuela MM, Milford TA, Payne KJ, Wall NR.

Cancer Microenviron. 2013 Apr;6(1):57-68. doi: 10.1007/s12307-012-0096-9. Epub 2012 Feb 10.

31.

Changes in mRNA expression of adenosine receptors in human chronic periodontitis.

Sun CX, Wall NR, Angelov N, Ririe C, Chen JW, Boskovic DS, Henkin JM.

Chin J Dent Res. 2011;14(2):113-20.

32.

Survivin-T34A: molecular mechanism and therapeutic potential.

Aspe JR, Wall NR.

Onco Targets Ther. 2010 Dec 6;3:247-54. doi: 10.2147/OTT.S15293.

33.

Cortical representations of olfactory input by trans-synaptic tracing.

Miyamichi K, Amat F, Moussavi F, Wang C, Wickersham I, Wall NR, Taniguchi H, Tasic B, Huang ZJ, He Z, Callaway EM, Horowitz MA, Luo L.

Nature. 2011 Apr 14;472(7342):191-6. doi: 10.1038/nature09714. Epub 2010 Dec 22.

34.

Monosynaptic circuit tracing in vivo through Cre-dependent targeting and complementation of modified rabies virus.

Wall NR, Wickersham IR, Cetin A, De La Parra M, Callaway EM.

Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21848-53. doi: 10.1073/pnas.1011756107. Epub 2010 Nov 29.

35.

Genetic dissection of an amygdala microcircuit that gates conditioned fear.

Haubensak W, Kunwar PS, Cai H, Ciocchi S, Wall NR, Ponnusamy R, Biag J, Dong HW, Deisseroth K, Callaway EM, Fanselow MS, Lüthi A, Anderson DJ.

Nature. 2010 Nov 11;468(7321):270-6. doi: 10.1038/nature09553.

36.

Dynamic changes to survivin subcellular localization are initiated by DNA damage.

Asumen MG, Ifeacho TV, Cockerham L, Pfandl C, Wall NR.

Onco Targets Ther. 2010 Sep 7;3:129-37.

37.

Survivin is released from cancer cells via exosomes.

Khan S, Jutzy JM, Aspe JR, McGregor DW, Neidigh JW, Wall NR.

Apoptosis. 2011 Jan;16(1):1-12. doi: 10.1007/s10495-010-0534-4.

38.

Microsatellite instability in endometrial polyps.

Rios SS, Andrade RV, Pereira RW, Wall NR, Bahjri K, Caldas É, Cavalcante L, Figueiredo F.

Eur J Obstet Gynecol Reprod Biol. 2010 Dec;153(2):193-7. doi: 10.1016/j.ejogrb.2010.07.028. Epub 2010 Aug 11.

39.

Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.

Mediavilla-Varela M, Pacheco FJ, Almaguel F, Perez J, Sahakian E, Daniels TR, Leoh LS, Padilla A, Wall NR, Lilly MB, De Leon M, Casiano CA.

Mol Cancer. 2009 Aug 28;8:68. doi: 10.1186/1476-4598-8-68.

40.

Enhanced antitumor effect of combined gemcitabine and proton radiation in the treatment of pancreatic cancer.

Galloway NR, Aspe JR, Sellers C, Wall NR.

Pancreas. 2009 Oct;38(7):782-90. doi: 10.1097/MPA.0b013e3181a85999.

41.

Cloning and characterization of Rhodotorula glutinis thymine hydroxylase.

Neidigh JW, Darwanto A, Williams AA, Wall NR, Sowers LC.

Chem Res Toxicol. 2009 May;22(5):885-93. doi: 10.1021/tx8004482.

PMID:
19341313
42.

IL-7 Dependence in human B lymphopoiesis increases during progression of ontogeny from cord blood to bone marrow.

Parrish YK, Baez I, Milford TA, Benitez A, Galloway N, Rogerio JW, Sahakian E, Kagoda M, Huang G, Hao QL, Sevilla Y, Barsky LW, Zielinska E, Price MA, Wall NR, Dovat S, Payne KJ.

J Immunol. 2009 Apr 1;182(7):4255-66. doi: 10.4049/jimmunol.0800489.

43.

Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential.

Khan S, Aspe JR, Asumen MG, Almaguel F, Odumosu O, Acevedo-Martinez S, De Leon M, Langridge WH, Wall NR.

Br J Cancer. 2009 Apr 7;100(7):1073-86. doi: 10.1038/sj.bjc.6604978. Epub 2009 Mar 17.

44.

Differential effect of proIGF-II and IGF-II on resveratrol induced cell death by regulating survivin cellular localization and mitochondrial depolarization in breast cancer cells.

Singh SK, Moretta D, Almaguel F, Wall NR, De León M, De León D.

Growth Factors. 2007 Dec;25(6):363-72. doi: 10.1080/08977190801886905.

45.

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

Dohi T, Beltrami E, Wall NR, Plescia J, Altieri DC.

J Clin Invest. 2004 Oct;114(8):1117-27.

46.

Regulation of dendritic protein synthesis by miniature synaptic events.

Sutton MA, Wall NR, Aakalu GN, Schuman EM.

Science. 2004 Jun 25;304(5679):1979-83.

47.

Yin Yang 1 is a negative regulator of p53.

Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR, Shi Y.

Cell. 2004 Jun 25;117(7):859-72.

48.

Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase.

Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA.

Science. 2004 Jul 16;305(5682):390-2. Epub 2004 Jun 17.

49.

Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin.

Chen J, Wall NR, Kocher K, Duclos N, Fabbro D, Neuberg D, Griffin JD, Shi Y, Gilliland DG.

J Clin Invest. 2004 Jun;113(12):1784-91.

50.

Small RNA: can RNA interference be exploited for therapy?

Wall NR, Shi Y.

Lancet. 2003 Oct 25;362(9393):1401-3. Review.

PMID:
14585643

Supplemental Content

Support Center